Clinical Senior Lecturer/Reader/Professor in Haematology and Cell Therapy

Division of Cancer and Genetics
School of Medicine
College of Biomedical and Life Sciences
Cardiff University
Cardiff University School of Medicine is seeking to appoint a Consultant Haematologist and Cell Therapy Academic Lead to provide leadership for translational haemato-oncology research, innovation, and education at Cardiff University.
The post holder will be responsible for building a scientific portfolio that aligns with, and supports, the cancer research strategy of the School, Cardiff University and Wales. These activities will be closely aligned with clinical research conducted by our NHS partners and offer the opportunity to drive world-leading research in a supportive, interdisciplinary and dynamic environment.
It is envisaged that the post holder will develop and lead an active cellular therapy research portfolio across haemato-oncology malignancies and solid cancers at Cardiff University. Depending on experience and expertise, the successful candidate may be a Clinical Academic, based primarily in the research clinic with links to the laboratory, or a Clinician Scientist, based primarily in the laboratory with links to the clinic.
The post holder will lead the Section of Haematology located in the Division of Cancer and Genetics (DCG). Here research involves development of novel drugs, immunotherapies and other highly targeted approaches, including cellular therapies and molecularly directed agents, as well as the identification of genetic changes and molecular disease characteristics that can be exploited to direct patient-specific therapy. Clinical research with expanding early phase clinical trial activity, molecular diagnostics and target identification is closely aligned with more basic laboratory research. The Haematology research groups work together across College themes to analyse various haematological cancers with respect to mechanisms of leukaemogenesis, leukaemic stem cells, drug development, animal models, microenvironmentally determined therapy resistance and novel cellular therapies. DCG is host to the Wales Cancer Research Centre (WCRC), Wales Gene Park (WGP) and Wales Cancer Bank (WCB) and has strong links with the Division of Infection and Immunity (DII), the Centre for Trials Research (CTR), the Medicines Discovery Institute (MDI), and the European Cancer Stem Cell Institute (ESCRI). The appointee will work closely with haemato-oncology colleagues in the Early Phase Clinical Trials Team and the Bone Marrow Transplant Team (BMT), solid cancer colleagues at Cardiff and Vale UHB (C&V UHB) and Velindre University NHS Trust, and scientists within the immunology and translational haematology laboratories at Cardiff University.
The appointee will also have the opportunity to play an active role within several cancer infrastructures at Cardiff University, including the recently re-funded Cardiff Experimental Cancer Medicine Centre (ECMC) and the Cardiff Cancer Research Hub (CCRH), a facility for clinical and translational cancer research based at the University Hospital of Wales, developed in partnership by Cardiff University with its NHS partners, Cardiff & Vale University Health Board and Velindre University NHS Trust. The CCRH will drive the immuno-oncology, cell therapy and Advanced Therapy Medicinal Products (ATMP) research portfolio in Cardiff in both haemato-oncology and solid cancers. There is an opportunity for the appointee to play a prominent role within the leadership team of CCRH which will be discussed with the successful candidate.
Cardiff University offers many excellent benefits, including 45 days annual leave (incl bank holidays), local pension scheme, a cycle to work scheme and other travel initiatives, annual increments within the pay scale, and more. It is an exciting and vibrant place to work, with many different challenges and is a proud Living Wage supporter.
This post is full-time (37½ hours per week), open-ended, and available immediately.
When submitting your application, please state which level (Clinical Senior Lecturer, Reader or Professor) you wish your application to be considered for.
Closing date: Monday 13 May 2024.
To work for an employer that values and promotes equality of opportunity, please click Apply Now and search for vacancy number 18159BR.
Cardiff University is committed to supporting and promoting equality and diversity and to creating an inclusive working environment. We believe this can be achieved through attracting, developing, and retaining a diverse range of staff from many different backgrounds. We therefore welcome applicants from all sections of the community regardless of sex, ethnicity, disability, sexual orientation, trans identity, relationship status, religion or belief, caring responsibilities, or age. In supporting our employees to achieve a balance between their work and their personal lives, we will also consider proposals for flexible working or job share arrangements.
Applications may be submitted in Welsh, and an application submitted in Welsh will not be treated less favourably than an application submitted in English.
#J-18808-Ljbffr